文献速递痛风与晶体性关节病

酸樱桃浓缩汁剂量对痛风患者血尿酸无影响

Lack of effect of tart cherry concentrate dose on serum urate in people with gout.
PubMed 文献 · Rheumatology (Oxford) · 2020-01-01

该随机对照试验纳入50例血尿酸>0.36 mmol/L的痛风患者,其中一半使用别嘌醇、一半未用降尿酸治疗,随机接受安慰剂或7.5、15、22.5、30 ml酸樱桃浓缩汁每日两次共28天。结果显示樱桃浓缩汁剂量对血尿酸曲线下面积、尿尿酸排泄、尿花青素变化及28天内痛风发作频率均无显著影响(P=0.76)。

要点

  • 酸樱桃浓缩汁剂量对痛风患者血尿酸曲线下面积无显著降低作用。
  • 酸樱桃浓缩汁对尿尿酸排泄及28天内痛风发作频率均无显著影响。
  • 别嘌醇使用与否不改变酸樱桃对血尿酸或尿尿酸排泄的作用。

核心结论

  • 酸樱桃浓缩汁对血尿酸和尿尿酸排泄均无影响,若其长期对痛风发作有作用,可能并非通过降低血尿酸介导。

研究设计与样本

  • 随机对照试验纳入50例血尿酸>0.36 mmol/L的痛风患者,一半使用别嘌醇、一半未用降尿酸治疗。
  • 参与者随机接受安慰剂或7.5 ml、15 ml、22.5 ml、30 ml酸樱桃浓缩汁每日两次,持续28天。

主要发现

  • 樱桃浓缩汁剂量对血尿酸曲线下面积降低无显著影响。
  • 樱桃浓缩汁剂量对尿尿酸排泄无显著影响。
  • 樱桃浓缩汁剂量对第0天至第28天尿花青素变化无显著影响。
  • 樱桃浓缩汁剂量对28天研究期间痛风发作频率无显著影响(P=0.76)。
  • 共报告24例不良事件,仅1例(高血糖)被认为可能与樱桃浓缩汁相关。

关键数值与推荐

  • 纳入标准为痛风且血尿酸>0.36 mmol/L。
  • 主要结局指标为28天研究期间血尿酸曲线下面积。

临床怎么用

  • 基于本试验结果,酸樱桃浓缩汁不被支持用于降低痛风患者血尿酸。
  • 别嘌醇使用状态不影响酸樱桃浓缩汁对血尿酸或尿尿酸排泄的作用。

局限性

  • 研究周期为28天,未评估更长期酸樱桃浓缩汁对痛风发作的影响。
  • 样本量50例,一半使用别嘌醇、一半未用降尿酸治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Cherry concentrate has been suggested to reduce serum urate (SU) and gout flares. The aims of this study were to determine the magnitude of the effect of tart cherry concentrate on SU in people with gout, the most effective dose of tart cherry concentrate for lowering SU, and adverse effects. METHODS: Fifty people with gout and SU > 0.36 mmol/l were recruited. Half were on allopurinol and half were on no urate-lowering therapy. Participants were randomized to receive tart cherry juice concentrate: placebo, 7.5 ml, 15 ml, 22.5 ml or 30 ml twice daily for 28 days. Blood samples were taken at baseline, then at 1, 3 and 5 h post cherry and then on days 1, 3, 7, 14, 21 and 28. The area under the curve for SU was calculated over the 28-day study period. RESULTS: Cherry concentrate dose had no significant effect on reduction in SU area under the curve, urine urate excretion, change in urinary anthocyanin between day 0 and day 28, or frequency of gout flares over the 28-day study period (P = 0.76). There were 24 reported adverse events, with only one (hyperglycaemia) considered possibly to be related to cherry concentrate. Allopurinol use did not modify the effect of cherry on SU or urine urate excretion. CONCLUSION: Tart cherry concentrate had no effect on SU or urine urate excretion. If there is an effect of cherry concentrate on gout flares over a longer time period, it is not likely to be mediated by reduction in SU. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry (ANZCTR), https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=368887, ANZCTR 12615000741583).

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Stamp LK, Chapman P, Frampton C, et al. Lack of effect of tart cherry concentrate dose on serum urate in people with gout. Rheumatology (Oxford). 2020. PMID: 31891407. doi:10.1093/rheumatology/kez606

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。